Global Life Science Company
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations
provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines FDA regulatory issues
Issues related to Priority Review Voucher programs
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
State Opioid Response Grants funding for FY 2021
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations
provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations
provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
DEF - Defense DIS - Disaster Planning/Emergencies HCR - Health Issues BUD - Budget/Appropriations HOM - Homeland Security
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
DOTCHIN & ASSOCIATES, LLC
412 North Saint Asaph Street, Alexandria, VA, 22314, US
ROBERT J. DOTCHIN ROBERT J. DOTCHIN ROBERT J. DOTCHIN ROBERT J. DOTCHIN ROBERT J. DOTCHIN